Intrepid Financial Planning Group LLC
Position in ATNM — Actinium Pharmaceuticals, Inc.
CIK 1641296
CARMEL, IN
Position in ATNM
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$10,447
-$3,833 QoQ
Shares Held
10,500
0.0% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#33
of 53 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ATNM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Intrepid Financial Planning Group LLC holds $197,913 across 3 Biotechnology names. ATNM ranks #3 (5.3% of the industry book) .
All Filings in ATNM
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,447 | 10,500 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $14,280 | 10,500 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $20,000 | 12,500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $17,500 | 12,500 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $23,345 | 14,500 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $17,640 | 14,000 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $35,720 | 19,000 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $148,000 | 20,000 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $125,280 | 16,000 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $81,280 | 16,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $106,560 | 18,000 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $133,560 | 18,000 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $179,550 | 19,000 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $213,000 | 20,000 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $147,600 | 20,000 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $96,200 | 20,000 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||